Disposition of [14C]-polystyrene microplastics after oral administration to lactating sheep

被引:0
|
作者
Shelver, Weilin L. [1 ]
McGarvey, Amy M. [1 ]
Billey, Lloyd O. [1 ]
机构
[1] US Agr Res Serv, Edward T Schafer Agr Res Ctr, USDA, Fargo, ND 58102 USA
基金
美国农业部;
关键词
Absorption; distribution; excretion; microplastics; polystyrene; sheep; GASTROINTESTINAL-TRACT; HEALTH-RISKS; PLASTICS; QUANTIFICATION; ACCUMULATION; INGESTION; PASSAGE; BIRDS; MILK; MEAL;
D O I
10.1080/19440049.2024.2379382
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Microplastics have become a ubiquitous contaminant, but their fate in food animals is largely unknown. In this study, [C-14]-polystyrene microplastic (PS-MP) particles were orally dosed to lactating sheep to evaluate their absorption and disposition. Elimination of the [C-14]-PS-MP was predominately through faeces with faecal radioactivity peaking at 24 h post-dosing but continuing to be present throughout the entire 72 h study period. Only a small fraction (<= 1%) of the dosed [C-14]-PS-MP was present in blood, milk, and urine. Pharmacokinetic analysis of blood plasma radioactivity, using non-compartment modeling, indicated rapid absorption (T-1/2 0.4 to 3 h) with slow elimination (T-1/2 37 to 48 h). Radioactivity in milk and urine had similar elimination patterns with radiocarbon activities peaking 24 h post-dosing with detectable elimination throughout the 72 h study period. No radioactivity was quantifiable in tissues at the 72 h withdrawal period.
引用
收藏
页码:1132 / 1143
页数:12
相关论文
共 50 条
  • [31] Disposition of [14C] ruboxistaurin in humans
    Burkey, Jennifer L.
    Campanale, Kristina M.
    Barbuch, Robert
    O'Bannon, Douglas
    Rash, James
    Benson, Charles
    Small, David
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (11) : 1909 - 1917
  • [32] Metabolism and Disposition of [14C]BMS-690514, an ErbB/Vascular Endothelial Growth Factor Receptor Inhibitor, after Oral Administration to Humans
    Christopher, Lisa J.
    Hong, Haizheng
    Vakkalagadda, Blisse J.
    Clemens, Pamela L.
    Su, Hong
    Roongta, Vikram
    Allentoff, Alban
    Sun, Haojun
    Heller, Kevin
    Harbison, Christopher T.
    Iyer, Ramaswamy A.
    Humphreys, William G.
    Wong, Tai
    Zhang, Steven
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (11) : 2049 - 2059
  • [33] DISPOSITION AND METABOLISM OF [2-C-14]EPICHLOROHYDRIN AFTER ORAL-ADMINISTRATION TO RATS
    GINGELL, R
    MITSCHKE, HR
    DZIDIC, I
    BEATTY, PW
    SAWIN, VL
    PAGE, AC
    DRUG METABOLISM AND DISPOSITION, 1985, 13 (03) : 333 - 341
  • [34] THE DISPOSITION AND METABOLISM OF [C-14] PIRITREXIM IN DOGS AFTER INTRAVENOUS AND ORAL-ADMINISTRATION
    WOOLLEY, JL
    DEANGELIS, DV
    GRACE, ME
    LIAO, SHT
    CROUCH, RC
    SIGEL, CW
    DRUG METABOLISM AND DISPOSITION, 1991, 19 (06) : 1139 - 1146
  • [35] THE DISPOSITION AND METABOLISM OF [C-14] PIRITREXIM IN RATS AFTER INTRAVENOUS AND ORAL-ADMINISTRATION
    WOOLLEY, JL
    DEANGELIS, DV
    CROUCH, RC
    SHOCKCOR, JP
    SIGEL, CW
    DRUG METABOLISM AND DISPOSITION, 1991, 19 (03) : 600 - 608
  • [36] THE METABOLIC DISPOSITION OF C-14-LABELED CARMOISINE IN THE RAT AFTER ORAL AND INTRAVENOUS ADMINISTRATION
    GALLI, CL
    MARINOVICH, M
    COSTA, LG
    FOOD AND CHEMICAL TOXICOLOGY, 1982, 20 (04) : 351 - 356
  • [37] Metabolism and disposition of a potent and selective JNK inhibitor [14C]tanzisertib following oral administration to rats, dogs and humans
    Atsriku, Christian
    Hoffmann, Matthew
    Ye, Ying
    Kumar, Gondi
    Surapaneni, Sekhar
    XENOBIOTICA, 2015, 45 (05) : 428 - 441
  • [38] Biotransformation of [14C]dasatinib:: In vitro studies in rat, monkey, and human and disposition after administration to rats and monkeys
    Christopher, Lisa J.
    Cui, Donghui
    Li, Wenying
    Barros, Anthony, Jr.
    Arora, Vinod K.
    Zhang, Haiying
    Wang, Lifei
    Zhang, Donglu
    Manning, James A.
    He, Kan
    Fletcher, Anthony M.
    Ogan, Marc
    Lago, Michael
    Bonacorsi, Samuel J.
    Humphreys, W. Griffith
    Iyer, Ramaswamy A.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (07) : 1341 - 1356
  • [39] Unique Metabolic Pathway of [14C]Lenvatinib after Oral Administration to Male Cynomolgus Monkey
    Inoue, Kazuko
    Asai, Naoki
    Mizuo, Hitoshi
    Fukuda, Katsuyuki
    Kusano, Kazutomi
    Yoshimura, Tsutomu
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (04) : 662 - 670
  • [40] Disposition and metabolic profile in monkey liver following single and multiple oral dosing of [14C]ribavirin and [14C]viramidine.
    Yeh, LT
    Lourenco, D
    Lin, CC
    HEPATOLOGY, 2003, 38 (04) : 746A - 746A